GSK3B and Alzheimer disease: Late-stage functionalizations of enantioenriched piperazinederivatives were demonstrated, including synthesis of a drug compoundwith glycogen synthase kinase (GSK)-3β inhibitor activity withpotential for treating Alzheimer’s disease.